These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 9443681)
1. Hemifacial spasm and other craniofacial movement disorders. Evidente VG; Adler CH Mayo Clin Proc; 1998 Jan; 73(1):67-71. PubMed ID: 9443681 [TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin for neurological disorders in a movement disorders clinic in Singapore. Tan AK Singapore Med J; 1998 Sep; 39(9):403-5. PubMed ID: 9885719 [TBL] [Abstract][Full Text] [Related]
3. [Hemifacial spasm]. Krystkowiak P Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S142-5. PubMed ID: 19576481 [TBL] [Abstract][Full Text] [Related]
4. Facial dystonia, essential blepharospasm and hemifacial spasm. Holds JB; White GL; Thiese SM; Anderson RL Am Fam Physician; 1991 Jun; 43(6):2113-20. PubMed ID: 2042553 [TBL] [Abstract][Full Text] [Related]
5. [Clinical symptoms, diagnosis and treatment of focal dystonias]. Klivényi P; Vécsei L Orv Hetil; 2001 Oct; 142(42):2293-7. PubMed ID: 11760645 [TBL] [Abstract][Full Text] [Related]
6. What is new in the era of focal dystonia treatment? Botulinum injections and more. Cetinkaya A; Brannan PA Curr Opin Ophthalmol; 2007 Sep; 18(5):424-9. PubMed ID: 17700237 [TBL] [Abstract][Full Text] [Related]
7. Effectivity of Dysport in patients with blepharospasm and hemifacial spasm who experienced failure with Botox. Badarny S; Susel Z; Honigman S Isr Med Assoc J; 2008 Jul; 10(7):520-2. PubMed ID: 18751631 [TBL] [Abstract][Full Text] [Related]
9. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm. Bihari K Curr Med Res Opin; 2005 Mar; 21(3):433-8. PubMed ID: 15811212 [TBL] [Abstract][Full Text] [Related]
10. Prospective, randomized, double-blind study, comparing botulinum toxins type a botox and prosigne for blepharospasm and hemifacial spasm treatment. Quagliato EM; Carelli EF; Viana MA Clin Neuropharmacol; 2010; 33(1):27-31. PubMed ID: 20124784 [TBL] [Abstract][Full Text] [Related]
11. Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorders. Hallett M; Albanese A; Dressler D; Segal KR; Simpson DM; Truong D; Jankovic J Toxicon; 2013 Jun; 67():94-114. PubMed ID: 23380701 [TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin in movement disorders. Papapetropoulos S; Singer C Semin Neurol; 2007 Apr; 27(2):183-94. PubMed ID: 17390263 [TBL] [Abstract][Full Text] [Related]
13. Blepharospasm and hemifacial spasm: a protocol for titration of botulinum toxin dose to the individual patient and for the management of refractory cases. Ortisi E; Henderson HW; Bunce C; Xing W; Collin JR Eye (Lond); 2006 Aug; 20(8):916-22. PubMed ID: 16531977 [TBL] [Abstract][Full Text] [Related]
14. A double-blind, randomized, crossover study of prosigne versus botox in patients with blepharospasm and hemifacial spasm. Rieder CR; Schestatsky P; Socal MP; Monte TL; Fricke D; Costa J; Picon PD Clin Neuropharmacol; 2007; 30(1):39-42. PubMed ID: 17272968 [TBL] [Abstract][Full Text] [Related]
16. Cranial dystonia, blepharospasm and hemifacial spasm: clinical features and treatment, including the use of botulinum toxin. Kraft SP; Lang AE CMAJ; 1988 Nov; 139(9):837-44. PubMed ID: 3052771 [TBL] [Abstract][Full Text] [Related]
17. [Blepharospasm and hemifacial spasm treated with botulinum A toxin injection]. Wang J; Lin S; Zhang X Zhonghua Er Bi Yan Hou Ke Za Zhi; 1998 Oct; 33(5):291-3. PubMed ID: 11717871 [TBL] [Abstract][Full Text] [Related]
18. [Treatment of movement disorders using botulinum toxin]. Burgunder JM Schweiz Med Wochenschr; 1992 Sep; 122(36):1311-6. PubMed ID: 1411387 [TBL] [Abstract][Full Text] [Related]
19. Quality of life in hemifacial spasm patient after treatment with botulinum toxin A; a 24-week, double-blind, randomized, cross-over comparison of Dysport and Neuronox study. Kongsengdao S; Kritalukkul S J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S48-54. PubMed ID: 22619887 [TBL] [Abstract][Full Text] [Related]